97 results on '"Giralt, S."'
Search Results
2. Historical reconstruction of sediment accumulation rates as an indicator of global change impacts in a tropical crater lake
3. Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
4. Potential ash impact from Antarctic volcanoes: Insights from Deception Island’s most recent eruption
5. Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
6. Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantation
7. Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis
8. Allogeneic hematopoietic cell transplantation in patients with AML not achieving remission: potentially curative therapy
9. Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants
10. PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies
11. Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis
12. A scoping review of caregiver burden during allogeneic HSCT: lessons learned and future directions
13. Peer review in hematopoietic cell transplantation: are we doing our fair share?
14. A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation
15. MRD-driven treatment paradigm for newly diagnosed transplant eligible multiple myeloma patients
16. Low incidence of GvHD with T-cell depleted allografts facilitates further treatments for post-transplantation relapse in AML and MDS
17. Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study
18. Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab era
19. The effects of the NAO on the ice phenology of Spanish alpine lakes
20. Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?
21. Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts
22. Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT
23. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia
24. Donor–recipient allele-level HLA matching of unrelated cord blood units reveals high degrees of mismatch and alters graft selection
25. Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up
26. Stem cell transplantation for multiple myeloma: current and future status
27. Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: incidence and prognostic significance
28. Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: experience at Memorial Sloan Kettering Cancer Center
29. Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis
30. Cancer-testis antigen expression and immunogenicity in AL amyloidosis
31. Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients’ monitoring after transplantation
32. Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation
33. Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
34. Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS
35. Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR
36. Prognostic value of response after upfront therapy for acute GVHD
37. Quantitative climate reconstruction linking meteorological, limnological and XRF core scanner datasets: the Lake Sanabria case study, NW Spain
38. Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma
39. Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT
40. CR represents an early index of potential long survival in multiple myeloma
41. Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome
42. Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML
43. Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?
44. Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population
45. Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research
46. Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome
47. Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation
48. Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation
49. Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies
50. Outcome of alveolar hemorrhage in hematopoietic stem cell transplant recipients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.